Skip to content
OpenCapital
Get started

10x Genomics, Inc. TXG Q3 2025 earnings

Reported November 6, 2025 · After market close

Revenue$149.0MBeat by $6.5M
EPS-$0.22Miss by $0.15
Revenue estimate$142.5M
EPS estimate-$0.07

Next report

Aug 6, 2026 (In 1 week)
Revenue estimate$146.7M
EPS estimate-$0.23

Financials

Q3 2025

Income statement

See full
Revenue$149.0M-1.7%
Gross profit$100.3M-5.7%
Operating income-$32.2M+22.3%
Net income-$27.5M+23.2%
EPS (diluted)-$0.22+26.7%

Balance sheet

See full
Cash & equivalents$432.7M+8.7%
Total debt$87.0M+1.3%
Total equity$785.1M+8.6%
Total assets$1.0B+9.6%

Cash flow

See full
Operating cash flow$43.2M+99.7%
CapEx$687.0K-82.3%
Free cash flow$42.5M+140%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$1.46B-46.3%
Enterprise value$1.11B-53.7%
P/S2.3×-2.0×

Profitability

See full
Gross margin68.8%+2.3pp
Operating margin-14.2%-5.1pp
Net margin-11.9%-4.4pp
FCF margin12.7%—

Returns & leverage

See full
Return on equity-10.1%-3.8pp
Debt / equity0.1×0.0×
Current ratio4.5×-0.4×

Segments

By product

See full
Products and services revenue$148.0M-2.3%
Chromium$92.5M-4.2%
Services$8.1M+29.0%
Spatial$7.1M-38.0%
License and royalty revenue$983.0K+935%

By geography

See full
Europe, Middle East and Africa$41.6M+10.0%
Asia-Pacific (excluding China)$12.3M+12.5%
Americas (excluding United States)$2.6M-15.3%

Versus estimates

Revenue

Q1 2026$150.8MBeat by $4.4MQ4 2025$166.0MBeat by $6.4M
Q3 2025$149.0MBeat by $6.5M
Q2 2025$172.9MBeat by $33.4MQ1 2025$154.9MBeat by $9.6MQ4 2024$165.0MIn line

Diluted EPS

Q1 2026-$0.10Beat by $0.19Q4 2025-$0.13Beat by $0.06
Q3 2025-$0.22Miss by $0.15
Q2 2025$0.28Beat by $0.63Q1 2025-$0.36Beat by $0.09Q4 2024-$0.40Miss by $0.11

Ask the moment 10x Genomics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did 10x Genomics, Inc. report Q3 2025 earnings?
10x Genomics, Inc. (TXG) reported Q3 2025 earnings on November 6, 2025 after market close.
What were 10x Genomics, Inc.'s Q3 2025 revenue and EPS?
10x Genomics, Inc. reported revenue of $149.0M and eps of $-0.22 for Q3 2025.
Did 10x Genomics, Inc. beat estimates in Q3 2025?
Revenue beat the consensus estimate of $142.5M by $6.5M. EPS missed the consensus estimate of $-0.07 by $0.15.
How did 10x Genomics, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 1.7% from $151.7M a year earlier and eps grew 26.7% from $-0.30.
Where can I find 10x Genomics, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001770787-25-000058) and the 10-Q periodic report (0001628280-25-050332) directly on SEC EDGAR. The filing index links above go to sec.gov.